Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01041261 · ClinicalTrials.gov registry record · NA
Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery
A NA study, sponsored by MetaProteomics.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01041261: Clinical Trial NA study, sponsored by MetaProteomics.
NCT01041261 is a NA study that was terminated before completion, run by MetaProteomics. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01041261, a NA study, was terminated before completion, sponsored by MetaProteomics.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
We propose to compare the standard of care with the use of a novel medical food in 6 bariatric surgery patients by measuring outcomes of body composition, quality of life, hair loss, muscle strength, resting energy expenditure, and biochemical parameters.
Interventions
- DIETARY_SUPPLEMENT BariatrX Essentials 360 Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01041261
The ClinicalTrials.gov registry entry for NCT01041261 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MetaProteomics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BariatrX Essentials 360 Treatment is the first listed.
NCT01041261 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01041261 about?
NCT01041261 is a clinical study titled "Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery". We propose to compare the standard of care with the use of a novel medical food in 6 bariatric surgery patients by measuring outcomes of body composition, quality of life, hair loss, muscle strength, resting energy expenditure, and biochemical parameters.
What is the current status of trial NCT01041261?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2009-09. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01041261?
The interventions under investigation include: BariatrX Essentials 360 Treatment (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01041261?
This trial is sponsored by MetaProteomics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.